Kenvue Inc. (NYSE:KVUE) shares are down during Thursday’s premarket session, with no news. Over the last six months, the company’s stock has fallen by around 15%.

In January, the company said it is moving forward with its acquisition process by Kimberly-Clark Corporation (NYSE:KMB).

Kenvue and Kimberly-Clark shareholders overwhelmingly approved the proposals necessary for Kimberly-Clark to complete its acquisition of Kenvue, with approximately 99% of shares voted in favor at Kenvue’s Special Meeting. The transaction is expected to close in the second half of 2026, pending regulatory approvals.

The approval marks a significant milestone in creating a global health and wellness leader, with Kenvue’s CEO, Kirk Perry, expressing confidence in the growth opportunities ahead for the combined company.

This merger aims to enhance innovation and expand access to their trusted brands, which include well-known names like Tylenol and Listerine.

In November 2025, a Texas judge declined to halt an upcoming shareholder payout by Texas Attorney General Ken ...